HFE haemochromatosis gene mutations in liver transplant patients

Autor: Judit Mäkinen, Krister Höckerstedt, Leena Halme, Tiina Heliö, K. Piippo, Martti Färkkilä, Tom Krusius, Kimmo Kontula
Rok vydání: 2001
Předmět:
Adult
Male
congenital
hereditary
and neonatal diseases and abnormalities

medicine.medical_specialty
Alcoholic liver disease
Pathology
Cirrhosis
Adolescent
medicine.medical_treatment
DNA Mutational Analysis
030204 cardiovascular system & hematology
Biology
Gene mutation
Liver transplantation
Gastroenterology
03 medical and health sciences
Liver disease
0302 clinical medicine
HLA Antigens
Internal medicine
medicine
Humans
Hemochromatosis Protein
Hemochromatosis
030304 developmental biology
Aged
DNA Primers
Hepatitis
0303 health sciences
Histocompatibility Antigens Class I
nutritional and metabolic diseases
Membrane Proteins
Middle Aged
medicine.disease
3. Good health
Liver Transplantation
Liver
030220 oncology & carcinogenesis
Hereditary hemochromatosis
Case-Control Studies
Mutation
030211 gastroenterology & hepatology
Female
Zdroj: Scandinavian journal of gastroenterology. 36(8)
ISSN: 0036-5521
Popis: The majority of patients with inherited haemochromatosis carry two mutant alleles of the recently discovered HFE gene. Individuals heterozygous for the HFE mutation could be predisposed to end-stage liver disease due to other causes.The frequencies of the HFE gene mutations C282Y and H63D were determined in DNA samples obtained from 189 liver transplant patients and 225 healthy Finnish blood donors.5% of the 189 liver transplant recipients were heterozygotes and 0.5% homozygotes for the C282Y mutation, while 16% were heterozygotes and 0.5% homozygotes for the H63D mutation. These figures were not increased in comparison to controls, of whom 11% were C282Y heterozygotes, 16% H63D heterozygotes and 0.9% H63D homozygotes. Among recipients with acute non-A-E hepatitis (n = 31), the frequency of the H63D allele was higher than in controls (21% versus 9.1%, P0.01). Perls' stain for iron in explanted liver specimens was positive in 28% of recipients with alcoholic cirrhosis, 26% of patients with acute non-A-E hepatitis and 14% in the rest of the recipients. The HFE genotypes did not correlate with the iron status.Individuals heterozygous for either the C282Y or H63D mutation of the HFE gene are not at increased risk of developing chronic end-stage liver disease. However, subjects heterozygous for the H63D mutation may have an increased risk to develop fulminant non-A-E hepatitis.
Databáze: OpenAIRE